Социальная ответственность бизнеса: опыт внедрения, характерные черты и особенности

Целью написания данной статьи является изучения опыта украинских предприятий (компаний) с наилучшими показателями в сфере социальной политики, выявление и анализ особенностей их реализации для разработки концептуального подхода к формированию модели внедрения принципов социальной ответственности в других компаниях (на предприятиях).Изучен опыт лучших компаний Украины в сфере корпоративной социальной ответственности; выявлены характерные черты и особенности разработки социальной политики в компании. Предложен концептуальный подход к формированию модели внедрения принципов социальной ответственности бизнеса.Вивчений досвід кращих компаній України в сфері соціальної відповідальності; виявлені характерні риси та особливості розробки соціальної політики в компанії. Запропонований концептуальний підхід до формування моделі впровадження принципів соціальної відповідальності бізнесу.The experience of the best Ukrainian companies in the sphere of the corporate social responsibility is studied; the personal traits and features of the development of social policy in a company are exposed. The conceptual approach is proposed to the formation of model of business social responsibility principles introduction

Biopolymer monitoring using quantitative image analysis techniques

Polyhydroxyalkanoates (PHAs) are intracellular biopolymers with many applications, particularly as substitutes of polypropylene and polyethylene, due to their thermoplastic properties and biocompatible nature. Furthermore, glycogen is a polysaccharide of glucose with high importance in the metabolism of microbial communities and polyphosphate is a microbial storage compound that should be recovered in order to offset the worldwide depletion of phosphorus sources. The determination of these biopolymers by chemical analysis is a laborious task, often involving digestion processes prior to gas and high-performance liquid chromatography, which are time consuming and difficult to apply in industry. Currently, it is important to develop new, rapid and simple techniques to monitor these polymers. Image analysis is a non-invasive and rapid technique that has the potential to be used to quantify these intracellular polymers quickly, in real-time. Mesquita et al. (2013) showed that it is possible to predict the concentration of glycogen and PHAs by quantitative image analysis, using aniline blue and nile blue staining, respectively. Polyphosphate can also be predicted by this technique through DAPI staining, which is currently under development. These biopolymers are produced by several different microorganisms, and combining their quantification with fluorescence in situ hybridization (FISH) techniques for microbial identification can enable the determination of organisms that store high quantities of each biopolymer. In this work, an advanced quantitative technique is developed to perform real time monitoring of these three biopolymers in a bioreactor performing biological phosphorus removal. Image analysis of the biopolymers was combined with FISH to determine the storage level of each compound within the different microbial populations. This technique will further enable the assessment of biopolymer levels within microbial communities, which can be applied in the biopolymer production industry

Microbial taxonomy in the post-genomic era: Rebuilding from scratch?

Microbial taxonomy should provide adequate descriptions of bacterial, archaeal, and eukaryotic microbial diversity in ecological, clinical, and industrial environments. Its cornerstone, the prokaryote species has been re-evaluated twice. It is time to revisit polyphasic taxonomy, its principles, and its practice, including its underlying pragmatic species concept. Ultimately, we will be able to realize an old dream of our predecessor taxonomists and build a genomic-based microbial taxonomy, using standardized and automated curation of high-quality complete genome sequences as the new gold standard.National Science Foundation (U.S.) (NSF Grant DEB-1046413)National Science Foundation (U.S.) (NSF Grant CNS-1305112)National Science Foundation (U.S.) (NSF Grant DEB 0918333)National Science Foundation (U.S.) (NSF grant OCE 1441943)Gordon and Betty Moore FoundationUnited States. Dept. of Energy. Office of ScienceUnited States. Dept. of Energy. Office of Biological and Environmental ResearchOak Ridge National LaboratoryCarlos Chagas Filho Foundation for Research Support of the State of Rio de JaneiroBrazil. Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (grant)Conselho Nacional de Pesquisas (Brazil

International Nosocomial Infection Control Consortiu (INICC) report, data summary of 43 countries for 2007-2012. Device-associated module

We report the results of an International Nosocomial Infection Control Consortium (INICC) surveillance study from January 2007-December 2012 in 503 intensive care units (ICUs) in Latin America, Asia, Africa, and Europe. During the 6-year study using the Centers for Disease Control and Prevention's (CDC) U.S. National Healthcare Safety Network (NHSN) definitions for device-associated health care–associated infection (DA-HAI), we collected prospective data from 605,310 patients hospitalized in the INICC's ICUs for an aggregate of 3,338,396 days. Although device utilization in the INICC's ICUs was similar to that reported from ICUs in the U.S. in the CDC's NHSN, rates of device-associated nosocomial infection were higher in the ICUs of the INICC hospitals: the pooled rate of central line–associated bloodstream infection in the INICC's ICUs, 4.9 per 1,000 central line days, is nearly 5-fold higher than the 0.9 per 1,000 central line days reported from comparable U.S. ICUs. The overall rate of ventilator-associated pneumonia was also higher (16.8 vs 1.1 per 1,000 ventilator days) as was the rate of catheter-associated urinary tract infection (5.5 vs 1.3 per 1,000 catheter days). Frequencies of resistance of Pseudomonas isolates to amikacin (42.8% vs 10%) and imipenem (42.4% vs 26.1%) and Klebsiella pneumoniae isolates to ceftazidime (71.2% vs 28.8%) and imipenem (19.6% vs 12.8%) were also higher in the INICC's ICUs compared with the ICUs of the CDC's NHSN